Overview

Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan

Status:
Completed

Trial end date:
2019-08-19

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy, safety and pharmacokinetics of MHOS/SHP615 administered buccally in children with status epilepticus (convulsive) in a healthcare setting.

Phase:

Phase 3

Details

Lead Sponsor:

Shire

Treatments:

Midazolam
Pharmaceutical Solutions